Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fate Therapeutics (FATE) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Fate Therapeutics (FATE) over the last 14 years, with Q3 2025 value amounting to $28.1 million.

  • Fate Therapeutics' Total Current Liabilities fell 2488.11% to $28.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.1 million, marking a year-over-year decrease of 2488.11%. This contributed to the annual value of $38.5 million for FY2024, which is 146.31% down from last year.
  • Fate Therapeutics' Total Current Liabilities amounted to $28.1 million in Q3 2025, which was down 2488.11% from $28.7 million recorded in Q2 2025.
  • Over the past 5 years, Fate Therapeutics' Total Current Liabilities peaked at $114.1 million during Q4 2022, and registered a low of $28.1 million during Q3 2025.
  • In the last 5 years, Fate Therapeutics' Total Current Liabilities had a median value of $45.4 million in 2024 and averaged $61.9 million.
  • As far as peak fluctuations go, Fate Therapeutics' Total Current Liabilities surged by 27946.16% in 2021, and later crashed by 6572.24% in 2023.
  • Quarter analysis of 5 years shows Fate Therapeutics' Total Current Liabilities stood at $81.3 million in 2021, then skyrocketed by 40.31% to $114.1 million in 2022, then plummeted by 65.72% to $39.1 million in 2023, then dropped by 1.46% to $38.5 million in 2024, then fell by 27.03% to $28.1 million in 2025.
  • Its Total Current Liabilities stands at $28.1 million for Q3 2025, versus $28.7 million for Q2 2025 and $28.2 million for Q1 2025.